Skip to Content

About: olga

Recent Posts by olga

Medisim Ltd. Selects Kopin’s Binocular Microdisplay Module for its BinoVision™ Head-Mounted Goggles

Medisim Ltd. Selects Kopin’s Binocular Microdisplay Module for its BinoVision™ Head-Mounted Goggles

August 31, 2020 07:30 AM Eastern Daylight Time

WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin® Corporation (NASDAQ: KOPN), a leading developer and provider of transmissive and reflective active matrix liquid crystal and organic light emitting diode (OLED) microdisplays and display subassemblies for military, enterprise, industrial, consumer and medical products, today announced that its BDM® WVGA LCD module and A912 Driver IC have been chosen by Medisim Ltd. for its BinoVision™ goggles.

“We are delighted that Medisim Ltd. has selected our products for its BinoVision™ goggles, and want to congratulate them on their success”

“Kopin’s knowledge of microdisplays and optical modules was very apparent to us during our process of selecting a near-to-eye LCD,” said Ilan Vadai, CEO, Medisim Ltd. “Kopin’s WVGA module and A912 ASIC were key components necessary to bring BinoVision™ to fruition. Kopin’s displays provide a high level of brightness – a key requirement for our application. In addition, with the displays and optics precisely aligned and securely packaged in a binocular module, the ease of integration was unmatched.”Medisim Ltd., based in Israel, developed the novel and patented product – BinoVision™, aiming to treat Amblyopia (Lazy Eye). The binocular head-mounted video goggle connects to most streaming video sources (computer, TV, game console, etc.) and uses the content (movies, cartoons, games, music videos, TV shows) to enable brain stimulation. BinoVision™ is content agnostic, so compliance is high. A published clinical study results of the technology showed that dichoptic stimulation of the visual system can significantly improve visual function in just 4 weeks. A feasibility study at Indiana University suggested BinoVision™ goggles, with some modifications, may also be used in the future for glaucoma. In a published study, the technology demonstrated increasing ocular blood flow and retinal perfusion both in glaucoma patients and healthy subjects.

“We are delighted that Medisim Ltd. has selected our products for its BinoVision™ goggles, and want to congratulate them on their success,” said Greg Truman, Head of Industrial and Enterprise Displays, Kopin. “We are excited by the increased interest in our microdisplays for medical products and believe a variety of applications such as surgical, procedural, ophthalmic and others can benefit from the integration of our near-to-eye microdisplays.”

Headquartered in Westborough, Massachusetts, Kopin and its subsidiaries offer a variety of industry leading microdisplay product lines, including LCD, OLED and FLCoS displays. Kopin’s BDM-WVGA (LCD) delivers a large (42″-diagonal size viewed at 6.5-foot distance), crisp image. The lightweight (16g), compact binocular display module integrates two 16: 9 widescreen CyberDisplay® WVGA LVD (854×480 resolution) color filter displays, LED backlights and a pair of pre-aligned high-quality lenses (30 degree field of view) into plastic housing. The BDM-WVGA is driven by Kopin’s A912 controller IC. The BDM-WVGA is a drop in solution, meant to speed up eyewear development and enable OEMs to design-in products quickly and efficiently.

Kopin, CyberDisplay and BDM are registered trademarks of Kopin Corporation.

About Kopin

Kopin Corporation is a leading developer and provider of innovative display and optical technologies sold as critical components and subassemblies for military, industrial and consumer products. Kopin’s technology portfolio includes ultra-small Active Matrix Liquid Crystal displays (AMLCD), Liquid Crystal on Silicon (LCOS) displays and Organic Light Emitting Diode (OLED) displays, a variety of optics, and low-power ASICs. For more information, please visit Kopin’s website at www.kopin.com.

About Medisim Ltd.

Medisim Ltd. is a developer and manufacturer of innovative diagnostic medical devices. Founded in 1995, Medisim’s headquarters and manufacturing plant are based in Israel, with subsidiaries in the USA and Hong Kong. As an R&D centric company, continually allocating substantial resources into developing innovative, cost-efficient and highly scalable medical solutions, Medisim is proud of its innovative spirit and contribution to enhancing peoples’ health. For more information, please visit Medisim website at: https://www.medisim.co.il

Forward-Looking Statements

Statements in this press release may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the safe harbor created by such sections. Words such as “expects,” “believes,” “can,” “will,” “estimates,” and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. We caution readers not to place undue reliance on any such “forward-looking statements,” which speak only as of the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. These forward-looking statements may include statements with respect to: Our belief that a variety of applications such as surgical, procedural, ophthalmic and others can benefit from the integration of our near-to-eye microdisplays. Various factors, some of which are beyond our control, could cause actual results to differ materially from those expressed in, or implied by, such forward-looking statements. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as may otherwise be required by the federal securities laws. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations are described in Part I, Item 1A. Risk Factors; Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form 10-K for the fiscal year ended December 28, 2019, or as updated from time to time in the Company’s Securities and Exchange Commission filings.

Contacts

Medisim Ltd.
Yossi Wittman
VP Business Development
yossiw@medisim.co.il
or
Richard Sneider, 508-870-5959
Treasurer and Chief Financial Officer
Richard_Sneider@kopin.com
or
Market Street Partners
Joann Horne, 415-445-3233
JHorne@marketstreetpartners.com

0 Continue Reading →

MEDISIM’S CONTINUOUS & NON-INVASIVE CORE TEMPERATURE MEASUREMENT AVAILABLE FOR MONITORING AWAKE AND ANESTHETIZED PATIENTS

  • Medical practitioners are aware of the importance of continuously monitoring core body temperature and its key role in determining patients’ outcomes; however due to challenges with traditional methods, its implementation was severely limited.
  • Temple Touch ProTM (TTPTM) is a non-invasive thermometry system, which measures core temperature continuously transmitting real-time data to any the patient monitor. The system is clinically proven accurate and reliable compared to gold standard invasive probes, and is FDA, CE, and PMDA approved.
  • Medisim is seeking partnerships with leading distributors to accelerate access to its technology.

For core temperature measurement, hospitals traditionally used various disposable/reusable invasive probes (such as Swan- Ganz pulmonary, esophageal, urinary and rectal), which may be prone to infections, and in many cases not used due to being troublesome to apply; inaccurate; uncomfortable for the patient; prohibitively expensive; non-continuous; or only applicable to fully anesthetized patients.

TTP™ eliminates the need for invasive temperature probes and offers hospitals a reliable and convenient solution, which is safe and affordable.

It is especially crucial in clinical settings such as in the Operating Room, Post-Anesthesia Care Unit and Intensive Care Units, and any other medical department where there is a necessity to continuously monitor core body temperature.

Non-Invasive core temperature monitoring for early detection of Sepsis

Sepsis is a leading cause of death and hospital re-admission and a major challenge in the Intensive Care Unit. Early sepsis detection is key – each hour of delay in diagnosis and treatment increases the risk for mortality. Existing sepsis diagnosis is lengthy and would benefit from continuous temperature measurements and data analysis tool.

TTP™ is currently being evaluated in a clinical trial “Non-Invasive core temperature monitoring as a measure for early detection of fever related infections”, conducted at Hadassah Ein Kerem University Medical Center by The Research Fund of Hadassah Medical Organization and under the supervision of Prof Vernon Van Heerden,  Head of Critical Care Medicine Unit, as the principal investigator of this clinical trial, and Dr. Magde AL-Barade, from Hadassah Ein Kerem University Medical Center. The study is in line with a predicate study in Boston “Body temperature patterns as a predictor of sepsis in ICU  patients”, by Anne M Drewry, Brian M Fuller, Thomas C Bailey, Richard S Hotchkiss, 2013, Critical Care, which showed that abnormal body temperature curves and patterns were predictive of the diagnosis of sepsis in afebrile critically ill patients. Analysis of temperature patterns, rather than absolute values, may facilitate decreased time to antimicrobial therapy.

About Medisim

Medisim Ltd. is a developer and manufacturer of innovative diagnostic medical devices.  Founded in 1995, Medisim’s headquarters and manufacturing plant are based in Israel, with subsidiaries in the USA and Hong Kong.   As a world leader in human body temperature measurement and monitoring, Medisim is developing and globally commercializing technologies and medical devices that enhance peoples’ health.

For more information, visit Medisim online at: https://www.medisim.co.il

0 Continue Reading →

Medica 2019

18-21 November 2019, Düsseldorf, Germany

The world’s leading trade fair for the medical industry, it attracted more than 5,100 exhibitors from 70 countries in 17 halls. Each year, leading individuals from the fields of business, research, and politics attend this top-class event

0 Continue Reading →

CMEF 2018

11-14 April 2018, Shanghai, China

The China International Medicinal Equipment Fair (CMEF) was launched in the year 1979 and is held twice every year, once in spring and once in autumn and includes exhibitions and forums. After 40 years of self-improvement and continuous development, the CMEF has now become one of the world’s leading global integrated service platforms in the value chain of medical devices.

More than 7,000 medical device manufacturers from over 30 different countries and regions have annually exhibited their products and services with us at the CMEF.

For trading and exchanging of medical products and services, about 2,000 specialists and talents and almost 200,000 visitors and buyers including government procurement agencies, hospital buyers and dealers from over 100 countries and regions gather at the CMEF.

0 Continue Reading →

Medica 2018

18-21 November 2018, Düsseldorf, Germany

Medica is the world’s largest event for the medical sector, with an established record of over 40 years. Medica has attracted more than 5000 exhibitors from 70 countries, who will display their products and solutions in 17 halls. Each year, leading individuals from the fields of business, research, and politics attend this top-class event, alongside tens of thousands of national and international experts and decision-makers from the sector.

0 Continue Reading →

Medica 2017

12-15 November 2017, Düsseldorf, Germany

The world’s leading trade fair for the medical industry, it attracted more than 5,100 exhibitors from 70 countries in 17 halls. Each year, leading individuals from the fields of business, research, and politics attend this top-class event, alongside tens of thousands of national and international experts and decision-makers from the sector.

0 Continue Reading →

Medisim showcases TTP at Anesthesiology 2016 Convention

Medisim displayed its TTP solution at the Anesthesiology 2016 Convention, which took place in October 2016, in Chicago.

Medisim’s TTP is an accurate, reliable noninvasive core temperature system for mass patient monitoring at healthcare centers.

The Anesthesiology 2016 Convention included 15,000 attendees from around the world. It was among the activities of the American Society of Anesthesiologists, an educational, research and scientific society with more than 52,000 members organized to raise and maintain the standards of the medical practice of anesthesiology.

0 Continue Reading →

Medisim introduces its Groundbreaking Binovision at the American Optometric Association Meeting 2016

Medisim revealed its revolutionary Binovision, an innovative Binocular Amblyopia Therapy, at the American Optometric Association meeting 2016.

Medisim’s Binovision uses entertaining audiovisual stimulation to encourage brain plasticity. BinoVision™ typically improves visual acuity in a short time. With just an hour a day, anywhere and anytime, and plug-and-play operation, Binovision streamlines usability for both parents. With this fun, easy, painless treatment, no eye patches or drops are needed.

The American Optometric Association, a leading authority on quality care represents more than 44,000 doctors of optometry (O.D.), optometric professionals and optometry students.

0 Continue Reading →

 

Recent Comments by olga

    No comments by olga